Concepedia

Ray Fucini

RF

Statistics

Publications

2

Citations

116

H-Index

2

Active since

2019

Affiliations

Carmot Therapeutics (United States)(Current)

Ray Fucini is an author at Carmot Therapeutics (United States) specializing in structure-based library design, potency optimization, and covalent drug design.

Publications per year

2019–2025

2

Publications

2

Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as Covalent Inhibitors of KRAS<sup>G12C</sup>

Youngsook Shin, Joon Won Jeong, Ryan P. Wurz et al. · ACS Medicinal Chemistry Letters · 2019 · 105 citations · Full text

, , +15

Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacy

Rubén Rodríguez, Anne C. Hergarden, Shyam Krishnan et al. · Cell Reports Medicine · 2025 · 11 citations · Full text

, , +17

1–2 of 2